NCT04871620

Brief Summary

The present study aims at assessing the ability of a new pulse contour device for diagnosing a \>15% stroke volume (SV) increase during patient hemodynamic optimization by fluid challenge in high risk abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2016

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 4, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2024

Completed
Last Updated

June 18, 2026

Status Verified

June 1, 2026

Enrollment Period

7.7 years

First QC Date

April 29, 2021

Last Update Submit

June 16, 2026

Conditions

Keywords

High risk abdominal surgeryhemodynamic optimizationstroke volumepulse contour

Outcome Measures

Primary Outcomes (1)

  • Ability of pulse contour for diagnosing a >15% increase in stroke volume

    Ability of pulse contour for diagnosing a \>15% increase in stroke volume

    15 minutes

Secondary Outcomes (2)

  • Comparison with the ability of other techniques

    15 minutes

  • Ability for predicting a >15% SV increase

    15 minutes

Study Arms (1)

Hemodynamic optimization

Patients scheduled for intermediate and high-risk abdominal surgery were eligible to participate

Diagnostic Test: >15% SV increase during fluid challenge

Interventions

The stroke volume will be measured before and after 15 minutes fluid challenge with crystalloids

Hemodynamic optimization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for intermediate and high-risk abdominal surgery were eligible to participate

You may qualify if:

  • Adult patient ASA status 1-3 who were orally informed and did refuse to participate.
  • Patient in whom general anesthesia with tracheal intubation were planned.
  • Patient in whom an arterial catheter and a monitoring of cardiac output by esophageal Doppler were indicated for hemodynamic optimization
  • Patient with cardiac sinusal mode

You may not qualify if:

  • Patient \< 18-year-old
  • Cardiac arrythmia
  • Patient with anomaly in oro-pharyngo-esophageal tractus
  • Patients with hemostasis anomaly (PT \< 30%, platelets \< 50 000 elements/mm3)
  • Patient in whom the cardiac output monitoring or measurement was not possible by Esophageal Doppler or echography
  • Patients in whom cardiac arrythmia occurred during the procedure of hemodynamic optimization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NIMES

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Cardiac Output, Low

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2021

First Posted

May 4, 2021

Study Start

April 12, 2016

Primary Completion

January 8, 2024

Study Completion

January 8, 2024

Last Updated

June 18, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations